RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Clinical trials for RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK explained in plain language.

Never miss a new study

Get alerted when new RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK trials appear

Sign up with your email to follow new studies for RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 2

New hope for Tough-to-Treat head and neck cancer: trial tests chemo timing

Disease control Not yet recruiting

This study aims to find the better way to give a chemotherapy drug called 5-FU to people with advanced head and neck cancer that has worsened after two standard treatments. It will compare giving the drug for two days every two weeks versus four days every three weeks. The main g…

Matched conditions: RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated Mar 30, 2026 14:27 UTC

RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Get alerted when new RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK trials appear

New hope for Tough-to-Treat head and neck cancer: trial tests chemo timing